The Latest Breaking News from Palantir

When US tech giant Palantir signed a £330 million contract with the NHS to operate its data platform, some sounded the alarm over patient privacy.

These two growth stocks appear to be well-positioned to capitalize on the AI wave.

Down about 38% from all-time highs, Palantir trades at a discount, especially if the AI software specialist can grow its earnings at a stellar pace going forward.

The mega-cap chipmaker shed more than 4% this week, creating headwinds for the S&P 500 and Nasdaq.

Shorting out-of-the-money puts in Palantir stock might be a good income opportunity. It could also be a good buy-in point in PLTR stock. This is based on a higher target price based on its strong FCF.

Palantir Technologies stock is attracting attention with its impressive AI-driven growth, major contracts, and partnerships, but its high valuation and mixed analyst sentiment raise questions about the sustainability of its rally and the likelihood of a significant breakout in the near term.

With the market back in bullish mode for now, it’s a good time to run Barchart’s Bull Call Spread Screener.

Top AI engineers at defence technology companies defended the need for autonomous weapons on Thursday, amid a push for a ban on so-called "killer robots". More than 115 countries and 250 non-governmental organisations are calling for an international treaty to ban weapons that use artificial intelligence to identify and engage…

Cabinet minister says move will help Jewish people feel safer at work

The secretive annual summit has tried to counter its arcane reputation, but its guest list still reads like a conspiracist’s who’s who of who rules the world

Palantir made strong free cash flow margins over the last year, and FCF could hit $900 million. As a result, PLTR stock could be worth 27% more. One way to play this is to short out-of-the-money (OTM) puts.